Malin Johannesson
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 3
- Peroxisome Proliferator-Activated Receptors 2
- Gene expression and cancer classification 1
-
- Alzheimer's disease research and treatments 7
- Co-authors
- Christer Möller (10 shared papers)Lars Lannfelt (9 shared papers)Linda Söderberg (8 shared papers)Patrik Nygren (4 shared papers)Gunilla Osswald (4 shared papers)Hanna Laudon (2 shared papers)Fredrik Eriksson (1 shared paper)Hans‐Erik Claesson (3 shared papers)
- Journals
- Alzheimer s & Dementia (3 papers)Neurotherapeutics (2 papers)Molecular and Cellular Neuroscience (2 papers)Scientific Reports (2 papers)Frontiers in Neuroscience (1 paper)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Malin Johannesson
15 papers receiving 617 citations
Malin Johannesson's Hit Papers
Peers
Comparison fields: 5 of 77
- Biological Psychiatry 46
- Physiology 334
- Neurology 85
- Neurology 136
- Pharmacology 119
Countries citing papers authored by Malin Johannesson
This map shows the geographic impact of Malin Johannesson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malin Johannesson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malin Johannesson more than expected).
Fields of papers citing papers by Malin Johannesson
This network shows the impact of papers produced by Malin Johannesson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malin Johannesson. The network helps show where Malin Johannesson may publish in the future.
Co-authors
The 25 scholars most cited alongside Malin Johannesson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease Hit paper breakdown → | 2022 | 289 |
| 2 | 2014 | 109 | |
| 3 | 2007 | 53 | |
| 4 | 2024 | 30 | |
| 5 | 2018 | 30 | |
| 6 | 2024 | 28 | |
| 7 | 2010 | 23 | |
| 8 | 2021 | 20 | |
| 9 | 2012 | 18 | |
| 10 | 2021 | 13 | |
| 11 | 2010 | 10 | |
| 12 | 2019 | 9 | |
| 13 | 2024 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2017 | 1 | |
| 16 | 2025 | 0 |
About Malin Johannesson
Malin Johannesson is a scholar working on Molecular Biology, Physiology, Neurology, Pharmacology and Cellular and Molecular Neuroscience, having authored 16 papers that have together received 635 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (7 papers), Parkinson's Disease Mechanisms and Treatments (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Peroxisome Proliferator-Activated Receptors (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers), Dementia and Cognitive Impairment Research (2 papers), Neurological disorders and treatments (1 paper) and Gene expression and cancer classification (1 paper). The work is most often cited by research in Biological Psychiatry (46 citations), Physiology (334 citations), Neurology (85 citations), Neurology (136 citations) and Pharmacology (119 citations). Malin Johannesson has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Christer Möller, Lars Lannfelt, Linda Söderberg, Patrik Nygren, Gunilla Osswald, Hanna Laudon, Fredrik Eriksson, Hans‐Erik Claesson, Linda Backman and Pontus Forsell. Their work appears in journals such as Alzheimer s & Dementia, Neurotherapeutics, Molecular and Cellular Neuroscience, Scientific Reports and Frontiers in Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.